Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Varicella-zoster Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03114982
What this trial is testing

The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age

Who this might be right for
Varicella
SK Chemicals Co., Ltd. 152
Testing effectiveness (Phase 2)Study completedNCT01527383
What this trial is testing

Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 354
Early research (Phase 1)Study completedNCT05871541
What this trial is testing

A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine

Who this might be right for
Herpes Zoster (HZ)ShinglesInfectious Disease
Immorna Biotherapeutics, Inc. 75
Post-approval studies (Phase 4)UnknownNCT05952505
What this trial is testing

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines

Who this might be right for
SARS-CoV-2 InfectionVaricellaMeasles+2 more
Shanghai Municipal Center for Disease Control and Prevention 540
Early research (Phase 1)UnknownNCT05750017
What this trial is testing

Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine

Who this might be right for
Herpes ZosterVaccine-Preventable Diseases
Beijing Luzhu Biotechnology Co., Ltd. 66
Large-scale testing (Phase 3)Study completedNCT00351923
What this trial is testing

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

Who this might be right for
MeaslesMumpsRubella+1 more
GlaxoSmithKline 330
Not applicableStudy completedNCT00156559
What this trial is testing

MMR and Varicella Vaccine in Premature Infants

Who this might be right for
ChickenpoxRubellaRubeola+1 more
University of Rochester 32
Large-scale testing (Phase 3)Study completedNCT00561080
What this trial is testing

Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)

Who this might be right for
Prevention of : Herpes-Zoster
Merck Sharp & Dohme LLC 759
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07205796
What this trial is testing

Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

Who this might be right for
Herpes Zoster
Shenzhen Shenxin Biotechnology Co., Ltd 480
Large-scale testing (Phase 3)Study completedNCT00130793
What this trial is testing

Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 368
Post-approval studies (Phase 4)UnknownNCT01982409
What this trial is testing

Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children

Who this might be right for
Chickenpox
Changchun Changsheng Life Science and Technology Co., Ltd. 350
Large-scale testing (Phase 3)Study completedNCT01610414
What this trial is testing

Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A

Who this might be right for
Herpes Zoster
GlaxoSmithKline 1,877
Testing effectiveness (Phase 2)Study completedNCT00434577
What this trial is testing

Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects

Who this might be right for
Herpes Zoster
GlaxoSmithKline 715
Early research (Phase 1)Study completedNCT00886613
What this trial is testing

Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 120
Post-approval studies (Phase 4)Study completedNCT05526820
What this trial is testing

Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A Vaccine

Who this might be right for
Varicella
Sinovac (Dalian) Vaccine Technology Co., Ltd. 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT05856084
What this trial is testing

Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 924
Large-scale testing (Phase 3)Looking for participantsNCT06088745
What this trial is testing

A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine

Who this might be right for
Vaccine-Preventable DiseasesHerpes Zoster
Beijing Luzhu Biotechnology Co., Ltd. 4
Large-scale testing (Phase 3)Study completedNCT04091451
What this trial is testing

Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster

Who this might be right for
Herpes Zoster
GlaxoSmithKline 1,430
Not applicableStudy completedNCT04089930
What this trial is testing

Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients

Who this might be right for
Lupus Erythematosus
Tuen Mun Hospital 68
Post-approval studies (Phase 4)UnknownNCT05596526
What this trial is testing

Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients

Who this might be right for
ShinglesZoster
Prof Patrice Lalive 100
Next Page